Biopsy Interpretation of the Skin 2nd Edition at Meripustak

Biopsy Interpretation of the Skin 2nd Edition

Books from same Author: A Neil Crowson MD

Books from same Publisher: Wolters Kluwer | Lippincott Williams & Wilkins

Related Category: Author List / Publisher List


  • Price: ₹ 12273.00/- [ 41.00% off ]

    Seller Price: ₹ 7241.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 41.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 41.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 41.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)A Neil Crowson MD
    PublisherWolters Kluwer | Lippincott Williams & Wilkins
    Edition2nd Edition
    ISBN9781496365132
    Pages648
    BindingHardbound
    LanguageEnglish
    Publish YearMarch 2018

    Description

    Wolters Kluwer | Lippincott Williams & Wilkins Biopsy Interpretation of the Skin 2nd Edition by A Neil Crowson MD

    Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Part of the popular Biopsy Interpretation Series, Biopsy Interpretation of the Skin: Primary Non-Lymphoid Cutaneous Neoplasia, Second Edition, is a concise, practical resource with a strong focus on diagnosis. It offers guidelines on how and when to biopsy the skin and provides superb coverage of common and uncommon non-lymphoid neoplasms of the skin. Focusing on the daily tasks and needs of the general pathologist, this updated Second Edition is an excellent bench reference and education resource for the interpretation of the most common skin biopsies. Incorporates recent advances in the biology of skin cancer which have led to important biologic therapies for melanoma, basal cell carcinoma, and squamous cell carcinoma.